RISEDRONATE-DRLA risedronate sodium 5 mg tablets blister pack

Țară: Australia

Limbă: engleză

Sursă: Department of Health (Therapeutic Goods Administration)

Ingredient activ:

risedronate sodium, Quantity: 5 mg

Disponibil de la:

Dr Reddys Laboratories Australia Pty Ltd

INN (nume internaţional):

Risedronate sodium

Forma farmaceutică:

Tablet, film coated

Compoziție:

Excipient Ingredients: microcrystalline cellulose; povidone; lactose monohydrate; magnesium stearate; crospovidone; titanium dioxide; hypromellose; macrogol 8000; hyprolose; colloidal anhydrous silica; iron oxide yellow; iron oxide red; macrogol 400

Calea de administrare:

Oral

Unități în pachet:

7, 14, 28, 84

Tip de prescriptie medicala:

(S4) Prescription Only Medicine

Indicații terapeutice:

? Treatment of osteoporosis ,? Treatment of glucocorticoid-induced osteoporosis ,? Preservation of bone mineral density in patients on long term corticosteroid therapy

Rezumat produs:

Visual Identification: Yellow,film coated,round,biconvex tablets,debossed with R5 on one side,plain on the other side; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statutul autorizaţiei:

Licence status A

Data de autorizare:

2012-10-03